الفهرس | Only 14 pages are availabe for public view |
Abstract This study was carried out in the Medical Microbiology and Immunology Department, Faculty of Medicine during one year from November 2021 to November 2022. The aimes of this study were to evaluate the levels of IL-6, IL-10 and interferon-gamma induced protein 10 (IP-10) before treatment, 24 hrs and 72 hrs after treatment with sarilumab using ELISA and also to correlate their levels with markers of disease severity in COVID-19 patients. |